A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Clinical trial NCT03512756 · TERMINATED

Trial details

NCT number: NCT03512756
Sponsor: Tyme, Inc
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2018-03-27
Primary completion: 2021-12-28
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.